NCT06813456View on ClinicalTrials.gov

Implementation of Solid Digital PCR to Support Gold-standard Methods for Evaluation of HER2 Amplification Status: Focus on HER2-low Subtype

RecruitingOBSERVATIONAL

Enrollment

234

Participants

Timeline

Start Date

November 8, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2028

Conditions

Breast Cancer

Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER